As of April 30, 2026, Alzai Health Corp. maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.14, indicating conservative leverage, while an interest coverage ratio of -105.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.33 |
| Quick Ratio | 0.30 |
| Debt / Equity | -63.14 |
| Debt / EBITDA | -0.23 |
| Interest Coverage | -105.93 |
These figures cover the twelve months ended April 30, 2026. EBITDA reached -2.66M, while operating income came in at -2.67M.
| Revenue | 19,904.89 |
| Operating Income | -2.67M |
| Pretax Income | -2.71M |
| Net Income | -2.71M |
| EBITDA | -2.66M |
| EBIT | -2.67M |
As of April 30, 2026, Alzai Health Corp. holds 197,343.95 in cash and equivalents against 613,871.36 in total debt, resulting in a net debt position of 416,527.41. Total book value stands at -972,249.17, with working capital of -640,903.70 providing operational flexibility.
| Cash & Cash Equivalents | 197,343.95 |
| Total Debt | 613,871.36 |
| Net Debt | 416,527.41 |
| Equity (Book Value) | -972,249.17 |
| Working Capital | -640,903.70 |
Alzai Health Corp. produced -1.91M in operating cash flow over the twelve months ended April 30, 2026.
| Operating Cash Flow | -1.91M |
| Capital Expenditures | -14,285.08 |
| Free Cash Flow | -1.92M |
These figures cover the twelve months ended April 30, 2026. The operating margin of -13,405.82 and net profit margin of -13,593.12 provide insight into operational efficiency.
| Operating Margin | -13,405.82 |
| Pretax Margin | -13,593.12 |
| Profit Margin | -13,593.12 |
| EBITDA Margin | -13,345.08 |
Already premium?